期刊文献+

Survivin在人星形细胞瘤中表达的意义及其与p16关系的研究 被引量:3

The expression of survivin and p16 proteins in human astrocytoma and its clinical significance
在线阅读 下载PDF
导出
摘要 目的研究凋亡抑制基因Survivin与抑癌基因p16在人星形细胞瘤中的表达及临床意义。方法利用免疫组化方法检测人星形细胞瘤Survivin及p16的表达,并对其表达与星形细胞瘤的病理学形态、组织学分级的关系进行分析。结果随着星形细胞瘤病理级别的增高,Survivin的阳性表达率及阳性表达强度逐渐增高(P<0.01),p16的阳性表达率及阳性表达强度逐渐降低(P<0.05)。结论p16的失活和Survivin的表达可能在星形细胞瘤的发生发展过程中起作用,可作为判断星形细胞瘤恶性程度和病理分级的辅助指标。 Objective To investigate the expression of survivin and p16 proteins in human astroeytoma and to evaluate its clinical significance. Methods The expressions of survivin and p16 were examined with SP immunohistochemieal technique. Results The positive rate and the expression intensity of survivin was increased with the pathological grades of astrocytomas (P〈0.01), On the contrary, the positive rate and the expressinn intensity of p16 was decreased with the tumor malignancy (P〈0.05). Conclusion The deficit expression of p16 and the expression of survivin may play a role in the develnpment of astrocytoma malignancy, h could be used as an assistant marker in pathological grading and prognosis of astroeytoma.
出处 《浙江医学》 CAS 2006年第1期1-3,21,共4页 Zhejiang Medical Journal
基金 浙江省医药卫生科学研究基金资助项目(2004B038)
关键词 星形细胞瘤 SURVIVIN P16 免疫组化染色 凋亡 凋亡抑制基因 Astrocytoma Survivin p16 Immunohistochemical staining Apotosis Tumor suppressor
  • 相关文献

参考文献10

  • 1彭黎明 王曾礼.细胞凋亡的基础和临床[M].北京:人民卫生出版社,2000.40-45.
  • 2Humphrey PA, Wong A J, Vogelstein B, et al. Amplification and expression of EGFR in Human glioma xenografts[J]. Cancer Res, 1998, 48:2 231-2 238.
  • 3伊新,曲喜英,林木生.凋亡抑制因子Survivin与肿瘤诊治的研究进展[J].中国癌症杂志,2003,13(2):182-185. 被引量:3
  • 4Verhagen AM, Ekort PG, Pakusch M, et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins[J]. Cell, 2000,102 (1):43-53.
  • 5Sasaki T, Lopes MB, Hankins GR, et al. Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system [J]. Acta Neuropathol, 2002,104 (1) : 105 - 109.
  • 6Suzuki A, Hayashida M, Ito T, et al. Survivin initiates cell cycle entry by the competitive interaction with Cdk4/pl6INK4a and Cdk2/CyclinE complex activation[J]. Oncogene, 2000,19 (29): 3 225-3 228.
  • 7Chakravati A, Komaga T, Firoozbakht F, et al. Placental growth factor is a survival factor for tumor endothelial cells and macrophages[J]. Cancer Res, 2002,62(10):2 749-2 752.
  • 8Serrano M, Hannon GY, Beach DA. A new regulatory motifin cell cycle control causing specific inhibition of cyclin D/CDK4[J].Nature,1993,366 (16):704-708.
  • 9Marx J. New tumor suppressor may rival p53[J]. Science ,1994,264: 344-347.
  • 10Lukas J, Aagaard L, Strauss M, et al. Oncogen icaberrations of p16ink4/CDKN2 and cyclinD1 cooperate to deregulate G1 control[J]. Cancer Res,1996,55:1 355-1 357.

二级参考文献20

  • 1[1]Krieg A, Mahotka C, Krieg T, et al. Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression[J]. Br J Cancer,2002,86(5): 737-743.
  • 2[2]Conway EM, Pollefeyt S, Cornelissen J, et al. Three differentially expressed survivin cDNA variants encoded proteins with distinct anti-apoptic functions[J]. Blood,2000,95(4):1435-1442.
  • 3[3]O'Connor DS, Grossman D, Plesica J, et al. Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin[J]. Proc Natl Acad Sci USA,2000,97(24): 13103-13107.
  • 4[4]Verhagen AM, Ekort PG, Pakusch M, et al. Identification of DIABLO , a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins[J]. Cell,2000,102(1): 43-53.
  • 5[5]Fortugno P, Wall NR, Giodini A, et al. Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function[J]. J Cell Sci,2002,115(3): 575-585.
  • 6[6]Kobayashi Y, Yukiue H, Sasaki H, et al. Developmentally regulated expression of survivin in the human thymus[J]. Hum Immunol,2002,63(2): 101-107.
  • 7[7]Satoh K, Kaneko K, Hirota M, et al. Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors[J]. Cancer,2001,92(2): 271-278.
  • 8[8]Kato J, Kuwabara Y, Mitani M, et al. Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy[J]. Int J Cancer,2001,95(2): 92-95.
  • 9[9]Ikeguchi M, Ueda T, Sakatani T, et al. Expression of survivin messenger RNA correlates with poor prognosis in patients with hepatocellular carcinoma[J]. Diagn Mol Pathol,2002,11(1): 33-43.
  • 10[10]Ikeguchi M, Liu J, Kaibara N, et al. Expression of survivin mRNA and protein in gastric cancer cell line (MKN-45) during cisplatin treatment[J]. Apoptosis,2002,7(1): 23-29.

共引文献5

同被引文献46

引证文献3

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部